Exact Mass: 492.26175700000005
Exact Mass Matches: 492.26175700000005
Found 198 metabolites which its exact mass value is equals to given mass value 492.26175700000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Bezitramide
C31H32N4O2 (492.25251319999995)
N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
Lurasidone
tetradehydro-17,4,5,6 3alpha cinchophylline
C31H32N4O2 (492.25251319999995)
Ala Phe Gln Lys
Ala Phe Lys Gln
Ala Lys Phe Gln
Ala Lys Gln Phe
Ala Gln Phe Lys
Ala Gln Lys Phe
Asp Phe Ile Val
Asp Phe Leu Val
Asp Phe Val Ile
Asp Phe Val Leu
Asp Ile Phe Val
Asp Ile Val Phe
Asp Leu Phe Val
Asp Leu Val Phe
Asp Val Phe Ile
Asp Val Phe Leu
Asp Val Ile Phe
Asp Val Leu Phe
Glu Phe Val Val
Glu Val Phe Val
Glu Val Val Phe
Phe Ala Lys Gln
Phe Ala Gln Lys
Phe Asp Ile Val
Phe Asp Leu Val
Phe Asp Val Ile
Phe Asp Val Leu
Phe Glu Val Val
Phe Ile Asp Val
Phe Ile Val Asp
Phe Lys Ala Gln
Phe Lys Gln Ala
Phe Leu Asp Val
Phe Leu Val Asp
Phe Gln Ala Lys
Phe Gln Lys Ala
Phe Val Asp Ile
Phe Val Asp Leu
Phe Val Glu Val
Phe Val Ile Asp
Phe Val Leu Asp
Phe Val Val Glu
Ile Asp Phe Val
Ile Asp Val Phe
Ile Phe Asp Val
Ile Phe Val Asp
Ile Pro Thr Tyr
Ile Pro Tyr Thr
Ile Thr Pro Tyr
Ile Thr Tyr Pro
Ile Val Asp Phe
Ile Val Phe Asp
Ile Tyr Pro Thr
Ile Tyr Thr Pro
Lys Ala Phe Gln
Lys Ala Gln Phe
Lys Phe Ala Gln
Lys Phe Gln Ala
Lys Gln Ala Phe
Lys Gln Phe Ala
Leu Asp Phe Val
Leu Asp Val Phe
Leu Phe Asp Val
Leu Phe Val Asp
Leu Pro Thr Tyr
Leu Pro Tyr Thr
Leu Thr Pro Tyr
Leu Thr Tyr Pro
Leu Val Asp Phe
Leu Val Phe Asp
Leu Tyr Pro Thr
Leu Tyr Thr Pro
Pro Ile Thr Tyr
Pro Ile Tyr Thr
Pro Leu Thr Tyr
Pro Leu Tyr Thr
Pro Thr Ile Tyr
Pro Thr Leu Tyr
Pro Thr Tyr Ile
Pro Thr Tyr Leu
Pro Tyr Ile Thr
Pro Tyr Leu Thr
Pro Tyr Thr Ile
Pro Tyr Thr Leu
Gln Ala Phe Lys
Gln Ala Lys Phe
Gln Phe Ala Lys
Gln Phe Lys Ala
Gln Lys Ala Phe
Gln Lys Phe Ala
Thr Ile Pro Tyr
Thr Ile Tyr Pro
Thr Leu Pro Tyr
Thr Leu Tyr Pro
Thr Pro Ile Tyr
Thr Pro Leu Tyr
Thr Pro Tyr Ile
Thr Pro Tyr Leu
Thr Tyr Ile Pro
Thr Tyr Leu Pro
Thr Tyr Pro Ile
Thr Tyr Pro Leu
Val Asp Phe Ile
Val Asp Phe Leu
Val Asp Ile Phe
Val Asp Leu Phe
Val Glu Phe Val
Val Glu Val Phe
Val Phe Asp Ile
Val Phe Asp Leu
Val Phe Glu Val
Val Phe Ile Asp
Val Phe Leu Asp
Val Phe Val Glu
Val Ile Asp Phe
Val Ile Phe Asp
Val Leu Asp Phe
Val Leu Phe Asp
Val Val Glu Phe
Val Val Phe Glu
Tyr Ile Pro Thr
Tyr Ile Thr Pro
Tyr Leu Pro Thr
Tyr Leu Thr Pro
Tyr Pro Ile Thr
Tyr Pro Leu Thr
Tyr Pro Thr Ile
Tyr Pro Thr Leu
Tyr Thr Ile Pro
Tyr Thr Leu Pro
Tyr Thr Pro Ile
Tyr Thr Pro Leu
29-demethylgeodisterol-O-sulfite
C27H40O6S (492.25454600000006)
lurasidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AE - Indole derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
tert-Butyl 4-(5-chloro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate
Bezitramide
C31H32N4O2 (492.25251319999995)
N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
Asp-Leu-Phe-Val
A tetrapeptide composed of L-aspartic acid, L-leucine, L-phenylalanine and L-valine joined in sequence by peptide linkages.
3-[[4-(diphenylmethyl)-1-piperazinyl]-oxomethyl]-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-12-one
C31H32N4O2 (492.25251319999995)
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4R,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4S,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4S,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4R,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4S,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4R,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-4-[(4R,5S)-5-[[cyclohexylmethyl(methyl)amino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4S,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4S,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4S,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4S,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4R,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(1R)-2-(cyclopropylmethyl)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1S)-2-(cyclopropylmethyl)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(3ar,6s,6ar,10s,12r,13r,15as)-1,6,12,13-tetrahydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
(3e,5s,7r,8r,10r,11r,12r,15r,16s,18e,25s)-11-acetyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20,26-hexaen-28-one
3,6-dibenzyl-8-hydroxy-4,9,11-trimethyl-12-propyl-1-oxa-4,7-diazacyclododec-7-ene-2,5,10-trione
1,6,12,13-tetrahydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
(3s,3ar,6s,6ar,10s,12r,13r,15as)-1,6,12,13-tetrahydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-3-carboxy-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-3-methylbutanoic acid
(2r,3r,12bs)-3-ethenyl-9-methoxy-2-({6-methoxy-9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
C31H32N4O2 (492.25251319999995)
11-acetyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20,26-hexaen-28-one
(3s,6s,9s,11s,12s)-3,6-dibenzyl-8-hydroxy-4,9,11-trimethyl-12-propyl-1-oxa-4,7-diazacyclododec-7-ene-2,5,10-trione
(3s,3ar,6s,6ar,10s,12r,13r,15ar)-1,6,12,13-tetrahydroxy-3-(1h-indol-3-ylmethyl)-4,5,10-trimethyl-3h,3ah,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
methyl 2-methyl-4,14,21,31-tetraazaoctacyclo[15.15.0.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁹,³¹.0²⁰,²⁸.0²²,²⁷]dotriaconta-3(11),5,7,9,15,20(28),22,24,26-nonaene-16-carboxylate
C31H32N4O2 (492.25251319999995)
(5s,7r,8r,10r,11r,12r,15r,16s,25s)-11-acetyl-2,20,27-trihydroxy-10-methyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20,26-hexaen-28-one
3-ethenyl-9-methoxy-2-({6-methoxy-9h-pyrido[3,4-b]indol-1-yl}methyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
C31H32N4O2 (492.25251319999995)